2-(2-pyridyl)ethylidine-1,1-bisphosphonate has been researched along with Bone Loss, Osteoclastic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Martin, MB; Oldfield, E; Szabo, CM | 1 |
Epstein, S; Fallon, M; Ismail, F; Movsowitz, C; Thomas, S | 1 |
Fleisch, H; Kozak, S; Rizzoli, R; Trechsel, U | 1 |
3 other study(ies) available for 2-(2-pyridyl)ethylidine-1,1-bisphosphonate and Bone Loss, Osteoclastic
Article | Year |
---|---|
An investigation of bone resorption and Dictyostelium discoideum growth inhibition by bisphosphonate drugs.
Topics: Alkyl and Aryl Transferases; Animals; Bone Resorption; Crystallography, X-Ray; Dictyostelium; Diphosphonates; Enzyme Inhibitors; Geranyltranstransferase; Humans; Inhibitory Concentration 50; Models, Molecular; Quantitative Structure-Activity Relationship; Rats | 2002 |
Hyperostosis induced by the bisphosphonate (2-PEBP) in the oophorectomized rat.
Topics: Animals; Body Weight; Bone Development; Bone Resorption; Calcium; Diphosphonates; Estradiol; Female; Hyperostosis; Osteocalcin; Ovariectomy; Parathyroid Hormone; Rats; Rats, Inbred Strains; Tibia | 1990 |
Effect of a single injection of two new bisphosphonates on the hypercalcemia and hypercalciuria induced by Walker carcinosarcoma 256/B in thyroparathyroidectomized rats.
Topics: Alendronate; Animals; Bone Resorption; Calcium; Carcinoma 256, Walker; Diphosphonates; Hypercalcemia; Kidney; Male; Parathyroid Glands; Rats; Rats, Inbred F344; Thyroidectomy | 1987 |